Articles from Butterfly Network, Inc.

Butterfly Network, Inc. (NYSEBFLY) (“Butterfly” or the “Company”), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, today announced the pricing of an underwritten public offering of 24,000,000 shares of its Class A common stock (the “Common Stock”), at a public offering price of $3.15 per share. The gross proceeds to Butterfly from the offering, before deducting underwriting discounts and commissions and other offering expenses, are expected to be approximately $75.6 million. Butterfly has granted the underwriters a 30-day option to purchase up to an additional 3,600,000 shares of Common Stock at the public offering price, less underwriting discounts and commissions.

Butterfly Network, Inc. (NYSEBFLY) (“Butterfly” or the “Company”), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, today announced it has commenced an underwritten public offering of Class A common stock (“Common Stock”). Butterfly also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of Common Stock sold in the public offering. All of the shares of Common Stock are being offered by Butterfly.

Butterfly Network, Inc. (“Butterfly”, “the Company”) (NYSEBFLY), a digital health company transforming care with handheld, whole-body ultrasound today announced preliminary findings from a seminal study conducted by Rutgers Robert Wood Johnson Medical School (RWJMS) and Robert Wood Johnson University Hospital (RWJUH), an RWJBarnabas Health facility, demonstrating the transformative impact of point-of-care ultrasound (POCUS) on patient outcomes and hospital efficiency. A late-breaking clinical trial presentation of the data was disseminated at the European Association of Cardiovascular Imaging’s EchoEuro-Imaging Conference in Berlin, Germany in December 2024.

Butterfly Network, Inc. (NYSEBFLY) (“Butterfly”, “the Company”), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, today announced that it expects to report revenue growth for the fourth quarter ended December 31, 2024 of approximately 35% year over year.

Butterfly Network, Inc. (NYSEBFLY) (“Butterfly”) a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that its management will present and host one-on-one meetings at the virtual BTIG Digital Health Forum on November 25, 2024.

Butterfly Network, Inc. (“Butterfly”) (NYSEBFLY), a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, today announced that Butterfly iQ3™, its third-generation handheld ultrasound device, was the recipient of the Best Medical Technology Award at the 2024 Prix Galien USA Awards by the Galien Foundation.

Butterfly Network, Inc. (NYSEBFLY) (“Butterfly”) a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced its participation at the Canaccord Genuity (CG) MedTech, Diagnostics and Digital Health & Services Forum in New York City on November 21, 2024.

Butterfly Network, Inc. (NYSEBFLY) (“Butterfly” or the “Company”), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, today announced financial results for the third quarter ended September 30, 2024, and provided a business update.

Butterfly Network, Inc. (NYSEBFLY) (“Butterfly”), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, announced that it will report third quarter 2024 financial results on November 1, 2024 at 8:00 am ET.

Butterfly Network, Inc. (“Butterfly”, “the Company”) (NYSEBFLY), a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, today published a case study highlighting the positive impact of University of Rochester Medical Center’s (URMC) transformative, system-wide deployment of Butterfly’s point-of-care ultrasound (POCUS) devices and enterprise ultrasound platform, Compass™. The results are backed by an academic paper published yesterday, September 16, 2024, in the Journal of Clinical Imaging Science.

Butterfly Network, Inc. (“Butterfly”) (NYSEBFLY), a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, today announced that Fierce Life Sciences and Fierce Healthcare have named Butterfly as one of 2024’s Fierce 50 honorees. The Fierce 50 showcases 50 individuals and companies driving advancements in medicine, fostering innovation, and shaping the future of biopharma and healthcare.

Butterfly Network, Inc. (NYSEBFLY) (“Butterfly”), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced its participation in Lake Street Capital Markets’ 8th Annual Best Ideas Growth Conference, taking place in New York City on September 12, 2024.

Butterfly Network, Inc. (NYSEBFLY), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, announced the appointment of Steve Cashman as Chief Business Officer (CBO), effective today. Cashman joins Butterfly at an exciting juncture, following the Company’s successful launch of its third-generation Butterfly iQ3 and historic revenue performance in the first half of 2024. Cashman will join Butterfly’s Executive Management Team, overseeing the Company’s global sales, marketing, product and corporate strategy.

Butterfly Network, Inc. (NYSEBFLY) (“Butterfly”), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced its participation in TD Cowen’s 9th Annual FutureHealth Conference, taking place in New York City on September 10, 2024.

Butterfly Network, Inc. (NYSEBFLY) (“Butterfly” or the “Company”), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, today announced financial results for the second quarter ended June 30, 2024, and provided a business update.

Butterfly Network, Inc. (NYSEBFLY) (“Butterfly”), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, announced that it will report second quarter 2024 financial results on August 1, 2024, after the market closes.

Butterfly Network, Inc. (NYSEBFLY) (“Butterfly”) a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that Joseph DeVivo, President, Chief Executive Officer and Chairman will present and host one-on-one investor meetings at the Goldman Sachs 45th Annual Global Healthcare Conference. The presentation will take place on Wednesday, June 12, 2024, at 10:00 am ET in Miami, Florida.

Butterfly Network, Inc. (“Butterfly”, “the Company”) (NYSEBFLY), a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, today introduced its first specialty product, iQ+ Bladder™, now available for purchase in the United States. The bundled solution includes an iQ+ Bladder probe, streamlined software, compact rolling cart, tablet and power splitter, paired with premium assembly. Combined, the solution offers a fit-for-purpose ultrasound-based bladder scanner that helps nurses get automated bladder volume calculations, with 3D visualizations, in seconds.

Butterfly Network, Inc. (NYSEBFLY) (“Butterfly” or the “Company”), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced financial results for the first quarter ended March 31, 2024, and provided a business update.

Butterfly Network, Inc. (NYSEBFLY) (“Butterfly”), a digital health company transforming care with handheld, whole-body ultrasound, announced that it will report first quarter 2024 financial results on May 1, 2024, after the market closes.

Butterfly Network, Inc. (NYSEBFLY) (“Butterfly”) a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, hosted its first investor day under President, Chief Executive Officer and Chairman, Joseph DeVivo. The event featured presentations from members of Butterfly’s executive and senior leadership team, providing insights into the Company’s product, software and services portfolio within its core point-of-care ultrasound market, as well as its strategic initiatives to expand into new markets.

Butterfly Network, Inc. (NYSEBFLY) (“Butterfly”) a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, will host its previously announced Investor Day on Monday March 18, 2024, beginning at 12:00pm ET at the New York Stock Exchange.

Butterfly Network, Inc. (NYSEBFLY) (“Butterfly”) a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that Joseph DeVivo, President, Chief Executive Officer and Chairman, and Heather Getz, Executive Vice President, Chief Financial and Operations Officer, will participate in a fireside chat and host one-on-one investor meetings at the Oppenheimer 34th Annual Healthcare MedTech & Services Conference on March 13, 2024, at 8:40 am ET. The conference will be held virtually.

Butterfly Network, Inc. (NYSEBFLY) (“Butterfly” or the “Company”), an innovative digital health company transforming care through a unique combination of portable, semiconductor-based ultrasound technology, intuitive software, services and educational offerings that can make medical imaging more accessible than ever before, today announced financial results for the quarter and year ended December 31, 2023, and provided a business update.

Butterfly Network, Inc. (NYSEBFLY) (“Butterfly”) a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that it will present and host one-on-one investor meetings at the TD Cowen 44th Annual Health Care Conference in Boston on March 5, 2024. Joseph DeVivo, President, Chief Executive Officer & Chairman, and Heather Getz, Executive Vice President & Chief Financial and Operations Officer will present at 9:10am ET.

Butterfly Network, Inc. (NYSEBFLY) (“Butterfly”), a digital health company transforming care with handheld, whole-body ultrasound, today announced that it will host an Investor Day on Monday March 18, 2024, beginning at 12:00pm ET at the New York Stock Exchange.

Butterfly Network, Inc. (NYSEBFLY) (“Butterfly”), a digital health company transforming care with handheld, whole-body ultrasound, today announced that it will report fourth quarter and full year 2023 financial results on Wednesday, February 28, 2024, after the market closes.

Butterfly Network, Inc. (“Butterfly”, “the Company”) (NYSEBFLY), a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, announced today the commercial launch of its third-generation handheld point-of-care ultrasound (POCUS) system, Butterfly iQ3™, which received FDA clearance last month. Butterfly iQ3 is powered by the Company’s most advanced semiconductor chip with a data transfer rate that is double that of its predecessor. The result is unparalleled image quality and faster micro-beamforming for advanced 3D capabilities: iQ Slice™ and iQ Fan™.

Butterfly Network, Inc. (“Butterfly”) (NYSEBFLY), a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, provided a business update today at the 42nd Annual J.P. Morgan Healthcare Conference. A webcast replay of the conference presentation can be viewed here, and will be available until February 10th, 2024. The presentation slide deck with animated videos can be accessed here.

Butterfly Network, Inc. (“Butterfly”) (NYSEBFLY), a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, today announced the FDA clearance of its next-generation handheld point-of-care ultrasound (POCUS) system, Butterfly iQ3. The new device is the company’s third iteration of the world’s first semiconductor-based single-probe, whole-body ultrasound system. Butterfly iQ3 features a brand-new ergonomic design and will deliver double the data processing speed for optimized image resolution, sensitivity and penetration, as well as faster 3D capabilities to power novel, automated image capture modes: iQ Slice and iQ Fan.

Butterfly Network, Inc. (NYSEBFLY) (“Butterfly”) a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that it will host one-on-one investor meetings at the 26th Annual Needham Growth Conference on January 16, 2024.

Butterfly Network, Inc. (“Butterfly”) (NYSEBFLY), a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, and Mendaera, a Silicon Valley-based company developing technology to help healthcare providers more easily and confidently perform procedures through the power of medical robotics, today announced an agreement to commercialize a novel robotic system that is Powered by Butterfly’s Ultrasound-on-Chip™ technology. Upon commercialization, the deal includes revenue share for every unit sold.

Butterfly Network, Inc. (NYSEBFLY) (“Butterfly”) a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that it will participate at the 42nd Annual J.P. Morgan Healthcare Conference taking place January 8-11, 2024, in San Francisco, California. Joseph DeVivo, President & Chief Executive Officer, and Heather Getz, Executive Vice President & Chief Financial Officer, will present on Thursday, January 11, 2024, at 9:00 AM PST.

Butterfly Network, Inc. (NYSEBFLY) (“Butterfly”) a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that it will participate at the Jefferies London Healthcare Conference taking place on November 14-16, 2023. Joseph DeVivo, Chief Executive Officer, and Heather Getz, Executive Vice President & Chief Financial Officer, will present on November 14, 2023, at 3:30 PM GMT.

Butterfly Network, Inc. (NYSEBFLY) (“Butterfly” or the “Company”), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced financial results for the quarter ended September 30, 2023, and provided a business update.

Butterfly Network, Inc. (“Butterfly”) (NYSEBFLY), a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, and Forest Neurotech, a deep tech research company that is building a minimally-invasive device for imaging and stimulating the brain with ultrasound, today announced they have entered into a five-year co-development agreement.

Butterfly Network, Inc. (NYSEBFLY) (“Butterfly”), a digital health company transforming care with handheld, whole-body ultrasound, announced that it will report third quarter 2023 financial results and provide a business update on November 2, 2023, after the market closes.

Butterfly Network, Inc. (“Butterfly”) (NYSEBFLY), a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, today announced the addition of two new ultrasound education offerings that will complete its full suite of education products. The new offerings will include:

Butterfly Network, Inc. a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, and Razom, a US-based nonprofit dedicated to supporting a democratic and prosperous Ukraine, today announced that they have expanded their global health partnership to bring an additional 200 Butterfly iQ+ devices to the frontlines of the war in Ukraine. Razom has now alone deployed over 400 Butterfly iQ+ devices to Ukraine, and has been a leader in driving Point-of-Care Ultrasound (POCUS) training and utilization in the country.

Butterfly Network, Inc., a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, issued a statement on the impact of its comprehensive point-of-care ultrasound (POCUS) solution, Butterfly iQ+, in advancing medical education curriculum nationally. The update follows news from Indiana University School of Medicine (IUSM) earlier this week announcing its investment in Butterfly iQ+ technology and enhanced training for its medical students, as well as faculty, residents and fellows across family medicine, internal medicine, emergency medicine, anesthesia, OB-GYN, surgery and critical care.

Butterfly Network, Inc. (NYSEBFLY) (“Butterfly” or the “Company”), a digital health company transforming care with handheld, whole-body ultrasound, today announced financial results for the quarter ended June 30, 2023, and provided a business update.

Butterfly Network, Inc. a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, today announced the release of its software development kit (SDK) for use by third parties. The SDK can be leveraged by artificial intelligence (AI) software developers, medical device companies building ultrasound into their platforms, and telemedicine companies adding ultrasound into their virtual care workflows. The kit will allow developers to utilize Butterfly’s platform to build custom applications that can be commercialized to Butterfly’s customer base – the largest user network in handheld point-of-care ultrasound.1 The Company ultimately plans to open “Butterfly Garden,” an AI Marketplace where new apps will be hosted for Butterfly users to discover and purchase the latest AI capabilities.

Butterfly Network, Inc. (NYSEBFLY) (“Butterfly”), a digital health company transforming care with handheld, whole-body ultrasound, announced that it will report second quarter 2023 financial results and provide a business update on August 3, 2023, before the market opens.

Butterfly Network, Inc. (NYSEBFLY) (“Butterfly” or the “Company”), a digital health company transforming care with handheld, whole-body ultrasound, today announced financial results for the quarter ended March 31, 2023, and provided a business update.

Butterfly Network, Inc. (NYSEBFLY) (“Butterfly”), a digital health company transforming care with handheld, whole-body ultrasound, announced that it will report first quarter 2023 financial results and provide a business update on May 11, 2023, before the market opens.

Butterfly Network, Inc., a digital health company transforming care through the power of handheld, whole-body ultrasound, has announced the appointment of Joseph M. DeVivo as its new President and Chief Executive Officer (CEO), effective immediately. Mr. DeVivo will also join Butterfly’s Board of Directors, serving as Chairman.

Butterfly Network, Inc., a digital health company transforming care through the power of handheld, whole-body ultrasound, announced today that it has received 510(k) clearance for a groundbreaking AI-enabled Auto B-line Counter that may simplify how healthcare professionals evaluate adults with suspected diminished lung function and can potentially accelerate their ability to make informed treatment decisions at the point of care.

Butterfly Network, Inc. (NYSEBFLY) ("Butterfly"), a digital health company transforming care with handheld, whole-body ultrasound, today announced that it will participate in the 33rd Annual Oppenheimer Healthcare Conference taking place virtually on March 13-15, 2023. Heather Getz, Executive Vice President & Chief Financial Officer, Darius Shahida, Chief Strategy Officer & Chief Business Development Officer, and Dr. John Martin, Chief Medical Officer will present on March 14, 2023 at 10:40am Eastern Time.

Butterfly Network, Inc. (NYSEBFLY) ("Butterfly"), a digital health company transforming care with handheld, whole-body ultrasound, today announced that it will participate in the 43rd Annual Cowen Health Care Conference taking place at the Boston Marriott Copley Place in Boston, MA on March 6-8, 2023. Heather Getz, Executive Vice President & Chief Financial Officer, Darius Shahida, Chief Strategy Officer & Chief Business Development Officer, and Dr. John Martin, Chief Medical Officer will participate in a fireside chat on March 7, 2023 at 2:10 pm Eastern Time.

Butterfly Network, Inc. (NYSEBFLY) (“Butterfly”), a digital health company transforming care with handheld, whole-body ultrasound, today announced financial results for the quarter ended December 31, 2022, and provided a business update.

For the first time in Europe, the University Hospital Bonn (UKB) and the Medical Faculty Bonn are using the advanced ultrasound system Butterfly Blueprint™ from the U.S.-headquartered digital health company, Butterfly Network, Inc., to teach medical and midwifery students at the UKB. The innovative, semiconductor chip-based Butterfly iQ+ can enable more informed diagnosis and treatment directly at the patient's bedside and support complex ultrasound training integrated into studies throughout the UKB campus.

Butterfly Network, Inc. (NYSEBFLY) (“Butterfly”), a digital health company transforming care with handheld, whole-body ultrasound, announced that it will report fourth quarter 2022 financial results and provide a business update on February 28, 2023, before the market opens.

Butterfly Network, Inc. (NYSEBFLY), a digital health company transforming care through the power of handheld, whole-body ultrasound, today announced the completion of phase one of its deployment and training program in Kenya. The program brought 500 Butterfly iQ+ devices and ultrasound training to local mid-level healthcare practitioners and was part of a larger effort – supported by a $5 million grant from the Bill & Melinda Gates Foundation – to equip 1,000 healthcare workers in Sub-Saharan Africa with Butterfly iQ+, the world’s only handheld, whole-body ultrasound probe to advance maternal and fetal health.

Butterfly Network, Inc. (NYSEBFLY) ("Butterfly"), a digital health company transforming care with handheld, whole-body ultrasound, today announced that it will participate in the 41st Annual J.P. Morgan Healthcare Conference taking place in San Francisco, California on January 9-12, 2023. Darius Shahida, Chief Strategy Officer & Chief Business Development Officer, and Heather Getz, Executive Vice President & Chief Financial Officer, will present on January 12, 2023 at 9:00 am Pacific Time at the Westin St. Francis Hotel, Elizabethan D conference room.

Butterfly Network, Inc. (NYSEBFLY) (“Butterfly” the “Company”), a digital health company transforming care with handheld, whole-body ultrasound, announced that the Company and Todd Fruchterman, M.D., Ph.D. have mutually agreed that Dr. Fruchterman will leave his position as President and Chief Executive Officer and as a member of the Board of Directors. Dr. Fruchterman will partner with Butterfly’s leadership team through the end of the year to ensure a smooth transition.

Butterfly Network, Inc. (NYSEBFLY) (“Butterfly”), a digital health company transforming care with handheld, whole-body ultrasound, today announced financial results for the quarter ended September 30, 2022, and provided a business update.

Butterfly Network, Inc. (NYSEBFLY) (“Butterfly”), a digital health company transforming care with handheld, whole-body ultrasound, announced that it will report third quarter 2022 financial results and provide a business update on November 3, 2022, before the market opens.

Butterfly Network, Inc. (NYSEBFLY) ("Butterfly"), a digital health company transforming care through the power of handheld, whole-body ultrasound and connected medicine, today announced a new Proficiency Management Solution offered as part of its enterprise imaging platform, Butterfly Blueprint™.

Butterfly Network, Inc. (NYSEBFLY), a digital health company transforming care through the power of handheld, whole-body ultrasound and connected medicine, today announced the deployment of 500 Butterfly iQ+ devices to healthcare practitioners in Kenya, at a ceremony at Kenyatta University. This deployment is supported by a $5 million grant from the Bill & Melinda Gates Foundation announced earlier this year that will provide 1,000 healthcare workers (predominantly midwives) in Sub-Saharan Africa with the world’s only handheld, whole-body ultrasound probe to advance maternal and fetal health.

Butterfly Network, Inc. (NYSEBFLY), a digital health company transforming care with handheld, whole-body ultrasound, today filed a motion to dismiss claims and specific patents from a complaint for patent infringement lawsuit filed on March 9, 2022, by FUJIFILM Sonosite Inc. Butterfly believes the lawsuit alleging infringement of U.S. Patent Nos. 7,169,108; 7,867,168; 8,128,050; 8,861,822; 9,538,985; 6,901,157; and 8,360,981, lacks merit and is meant to distract from FUJIFILM Sonosite’s failure to innovate and keep pace with Butterfly’s next generation clinical assessment platform.

Butterfly Network, Inc. (NYSEBFLY) (“Butterfly”), a digital health company transforming care with handheld, whole-body ultrasound, today announced financial results for the quarter ended June 30, 2022, and provided a business update.

Butterfly Network, Inc. (NYSEBFLY) (“Butterfly”), a digital health company transforming care with handheld, whole-body ultrasound, announced that it will report second quarter 2022 financial results and provide a business update on August 3, 2022, before the market opens.

Butterfly Network, Inc. (NYSEBFLY), a digital health company transforming care with handheld, whole-body ultrasound, and The Medical University of South Carolina (MUSC) announced today that MUSC will leverage Butterfly Blueprint,™ the company’s system-wide ultrasound platform. Together with Butterfly, MUSC aims to transform patient care, health education, and medical research by empowering its clinicians, students, and researchers with point-of-care access to AI-powered, handheld ultrasound.

Butterfly Network, Inc. (NYSEBFLY) ("Butterfly"), a digital health company transforming care with handheld, whole-body ultrasound, today announced that it will participate in the UBS Global Healthcare Conference to be held in New York, NY, on May 23-25, 2022.

Butterfly Network, Inc. (NYSEBFLY), a digital health company transforming care with handheld, whole-body ultrasound, today announced the appointment of Tamara Dillon to the position of Chief People Officer (CPO), effective May 31, and Larry Weiss to the position of Chief Legal Officer and Corporate Secretary, effective May 23.

Butterfly Network, Inc. (NYSEBFLY) (“Butterfly”), a digital health company transforming care with handheld, whole-body ultrasound, today announced financial results for the quarter ended March 31, 2022, and provided a business update.

Butterfly Network, Inc. (NYSEBFLY), a digital health company transforming care with handheld, whole-body ultrasound, today announced the appointment of Heather Getz to the position of Executive Vice President and Chief Financial Officer, effective May 2.

Butterfly Network, Inc. (NYSEBFLY), (the company) a digital health company transforming care with handheld, whole-body ultrasound, today announced its position in a new study published in NEJM Evidence, which introduces a significant opportunity to democratize obstetric ultrasound.

Butterfly Network, Inc. (NYSEBFLY) (“Butterfly”), a digital health company transforming care with handheld, whole-body ultrasound, announced that it will report first quarter 2022 financial results and provide a business update on May 5, 2022, before the market opens.

Butterfly Network, Inc. (NYSEBFLY) (“Butterfly”), a digital health company transforming care with handheld, whole-body ultrasound, today announced financial results for the quarter and full year ended December 31, 2021, and provided a business update.

Butterfly Network, Inc. (NYSEBFLY), a digital health company transforming care with handheld, whole-body ultrasound, today introduced Butterfly Blueprint™, a system-wide platform designed to support the scaled deployment of ultrasound across hospitals and health systems to empower more-informed clinical decisions from the bedside and encounter-based workflow.

Butterfly Network, Inc. (NYSEBFLY) ("Butterfly"), today announced that it will participate in Cowen’s 42nd Annual Health Care Conference to be held virtually on March 7-9, 2022. Dr. Todd Fruchterman, President and CEO will participate in a virtual fireside chat on Wednesday, March 9, 2022, at 10:30 am Eastern Time.

Butterfly Network, Inc. (NYSEBFLY) (“Butterfly”), a digital health company transforming care with handheld, whole-body ultrasound, announced that it will report fourth quarter and full year 2021 financial results and provide a business update on February 28, 2022, before the market opens.

Butterfly Network, Inc. (NYSEBFLY), a digital health company transforming care with handheld, whole-body ultrasound, and Ambra Health, an Intelerad Company, and maker of a leading cloud-based, medical image management suite, today announced a partnership to accelerate and simplify interoperability for bedside imaging data. This partnership strengthens the scalability of Butterfly Blueprint™, Butterfly’s enterprise platform, and will enhance access to, and shareability of valuable ultrasound information across hospitals and health systems.

Butterfly Network, Inc. (NYSEBFLY) ("Butterfly" or the “Company”), a digital health company transforming care with next generation, point-of-care ultrasound (“POCUS”), today announced certain preliminary, unaudited results for the quarter and full year ended December 31, 2021.